Down-titration of omalizumab in a patient with chronic spontaneous urticaria
Background: Omalizumab was demonstrated to be effective in patients with chronic urticaria resistant to antihistamines and is recommended as an add-on, third line treatment for such subjects. Patient and results: This article reports the history of a patient affected by chronic spontaneous urticaria...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2018.1529379 |